IE 11 is not supported. For an optimal experience visit our site on another browser.

New migraine drug offers unprecedented relief, but some insurance plans don’t cover it


A new group of injectable drugs inhibit a protein thought to trigger migraines, but not all insurance plans cover it -- and many people can’t afford the $575 a month price tag.